Rapamycin inhibits vascular smooth muscle cell migration

Journal of Clinical Investigation

Volumn 98, Issue 10, 1996, Pages 2277-2283

  Poon, Michael ^a   Marx, Steven O ^a   Gallo, Richard ^a   Badimon, Juan José ^a   Taubman, Mark B ^a   Marks, Andrew R ^a,b  

^a Cardiovascular Institute   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

atherosclerosis; FK506; FKBP12; immunophilin; restenosis

Indexed keywords

PLATELET DERIVED GROWTH FACTOR BB; RAPAMYCIN;

ANIMAL CELL; ARTICLE; ATHEROSCLEROSIS; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; RAT; RESTENOSIS; TRANSLUMINAL CORONARY ANGIOPLASTY; VASCULAR SMOOTH MUSCLE;

EID: 0029845013     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI119038     Document Type: Article

References (40)

1. Ross, R. 1993. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature (Lond.). 362:801-809.
2. Ip, J., V. Fuster, D. Israel, L. Badimon, J. Badimon, and J. Chesebro. 1991. The role of platelets, thrombin and hyperplasia in restenosis after coronary angioplasty. J. Am. Coll. Cardiol. 77B-88B.
3. Billingham, M. 1987. Cardiac transplant atherosclerosis. Transplantation Proc. 19 (Suppl. 5):19-25.
4. Casscells, W. 1992. Migration of smooth muscle and endothelial cells: critical events in restenosis. Circulation. 86:723-729.
5. Pauly, R.R., A. Passanti, C. Bilato, R. Monticone, L. Cheng, N. Papadopoulos, Y.A. Gluzband, L. Smith, C. Weinstein, E.G. Lakata, and M.T. Crow. 1994. Migration of cultured vascular smooth cells through a basement membrane barrier requires type IV collagenase activity and inhibited by cellular differentiation. Circ. Res. 75:41-54.
6. Clowes, A., and S.M. Schwartz. 1985. Significance of quiescent smooth muscle migration in the injured rat carotid artery. Circ. Res. 56:139-145.
7. Grotendorst, G.R., H.E.J. Seppa, H.K. Kleinman, and G.R. Martin. 1981. Attachment of smooth muscle cells to collagen and their migration toward platelet derived growth factor. Proc. Natl. Acad. Sci. USA. 78:3669-3672.
8. Ihnatowycz, I.O., P.D. Winocour, and S. Moore. 1981. A platelet-derived factor chemotatic for rabbit smooth muscle cells in culture. Artery. 9:316-317.
9. Ferns, G., E. Raines, K. Sprugel, A. Motani, M. Reidy, and R. Ross. 1991. Inhibition of neointimal smooth muscle accumulation after angioplasty by an antibody to PDGF. Science (Wash. DC). 253:1129-1132.
10. Jawien, A., D.F. Bowen-Pope, V. Lindner, S.M. Schwartz, and A.W. Clowes. 1992. Platelet-derived growth factor promotes smooth muscle migration and intimal thickening in a rat model of balloon angioplasty. J. Clin. Invest. 89:507-511.
11. Marx, S.O., T. Jayaraman, L.O. Go, and A.R. Marks. 1995. Rapamycin-FKBP inhibits cell cycle regulators of proliferation in vascular smooth muscle cells. Circ. Res. 76:412-417.
12. Nelson, P.A., J.A. Lippke, M.A. Murcko, S.L. Rosborough, and D.A. Peattie. 1991. cDNA encoding murine FK506-binding protein (FKBP): nucleotide and deduced amino acid sequences. Gene. 109:255-258.
13. Sewell, T.J., E. Lam, M.M. Martin, J. Leszyk, J. Weidner, J. Calaycay, P. Griffin, H. Williams, S. Hung, J. Cryan et al. 1994. Inhibition of calcineurin by a novel FK-506-binding protein. J. Biol. Chem. 269:21094-21102.
14. Standaert, R.F., A. Galat, G. Verdine, and S.L. Schreiber. 1990. Molecular cloning and overexpression of the human FK506-binding protein FKBP. Nature (Lond.). 346:671-674.
15. Hendrickson, B.A., W. Zhang, R.J. Craig, Y.-J. Jin, B.E. Bierer, S. Burakoff, and A.G. DiLella. 1993. Structural organization of the genes encoding human and murine FK506-binding protein (FKBP) 13 and comparison to FKBP1. Gene. 134:271-275.
16. Jayaraman, T., A.-M.B. Brillantes, A.P. Timerman, H. Erdjument-Bromage, S. Fleischer, P. Tempst, and A.R. Marks. 1992. FK506 binding protein associated with the calcium release channel (ryanodine receptor). J. Biol. Chem. 267:9474-9477.
17. Bierer, B., P.K. Somers, T.J. Wandless, S.J. Burakoff, and S.L. Schreiber. 1990. Probing immunosuppressant action with a nonnatural immunophilin ligand. Science (Wash. DC). 250:556-559.
18. 2+ mobilization and protein kinase C activation. J. Clin. Invest. 91:547-552.
19. Bornfeldt, K.E., E.W. Raines, T. Nakano, L.M. Graves, E.G. Krebs, and R. Ross. 1994. Insulin-like growth factor-I and platelet-derived growth factor-BB induce directed migration of human arterial smooth muscle cells via signaling pathways that are distinct from those of proliferation. J. Clin. Invest. 93:1266-1274.
20. Sambrook, J., E.F. Fritsch, and T. Maniatis. 1989. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY. 709 pp.
21. Gregory, C., P. Huie, M. Billingham, and R. Morris. 1993. Rapamycin inhibits arterial intimal thickening caused by both alloimmune and mechanical injury. Transplantation. 55:1409-1418.
22. Brown, E., M. Albers, T. Shin, K. Ichikawa, C. Keith, W. Lane, and S. Schreiber. 1994. A mammalian protein targeted by G1-arresting rapamycin-receptor complex. Nature (Lond.). 369:756-758.
23. Sabatini, D., H. Erdjument-Bromage, M. Lui, P. Tempst, and S. Snyder. 1994. RAFT1: a mammalian protein that binds to FKBP12 in a rapamycin-dependent fashion and is homologous to yeast TORs. Cell. 78:35-43.
24. Kuo, C.J., J. Chung, D.F. Fiorentino, W.M. Flanagan, J. Blenis, and G.R. Crabtree. 1992. Rapamycin selectively inhibits interleukin-2 activation of p70 S6 kinase. Nature (Lond.). 358:70-73.
25. Price, D.J., J.R. Grove, V. Calvo, J. Avruch, and B.E. Bierer. 1992. Rapamycin-induced inhibition of the 70-kilodalton S6 protein kinase. Science (Wash. DC). 257:973-977.
26. Nourse, J., E. Firpo, M.W. Flanagan, M. Meyerson, K. Polyak, M.-H. Lee, J. Massagué, G.R. Crabtree, and J.M. Roberts. 1994. Rapamycin prevents IL-2-mediated elimination of the cyclin-CDK kinase inhibitor, p27Kip1. Nature (Lond.). 372:570-573.
27. Stossel, T. 1989. From signal to pseudopod. J. Biol. Chem. 264:18621-18624.
28. Pauly, R.R., C. Bilato, S.J. Sollott, R. Monticone, P.T. Kelly, E.G. Lakatta, and M.T. Crow. 1995. Role of calcium/calmodulin-dependent protein kinase II in the regulation of vascular smooth muscle cell migration. Circulation. 91:1107-1115.
29. Kundra, V., J.A. Escobedo, A. Kazlauskas, H.K. Kim, S.G. Rhee, L.T. Williams, and B.R. Zetter. 1994. Regulation of chemotaxis by the platelet-derived growth factor receptor-β. Nature (Lond.). 367:474-476.
30. Shariff, A., and E.J. Luna. 1992. Diacylglycerol-stimulated formation of actin nucleation sites at plasma membranes. Science (Wash. DC). 256:245-247.
31. Rijken, P.J., W.J. Hage, P.M.P. van Begen en Henegouwen, A.J. Verkleij, and J. Boonstra. 1991. Epidermal growth factor induces actin organization of the actin microfilament system in human A431 cells. J. Cell Sci. 100:491-499.
32. Heitman, J., N.R. Movva, and M.N. Hall. 1991. Targets for cell cycle arrest by the immunosuppressant rapamycin in yeast. Science (Wash. DC). 253: 905-909.
33. Wang, T., P.K. Donahoe, and A.S. Zervos. 1994. Specific interaction of type I receptors of the TGF-beta family with the immunophilin FKBP-12. Science (Wash. DC). 265:674-676.
34. Michnick, S.W., M.K. Rosen, T.J. Wandless, M. Karplus, and S.L. Schreiber. 1991. Solution structure of FKBP, a rotamase enzyme and receptor for FK506 and rapamycin. Science (Wash. DC). 252:836-839.
35. Van Duyne, G.D., R.F. Standaert, P.A. Karplus, S.L. Schreiber, and J. Clardy. 1993. Atomic structures of the human immunophilin FKBP-12 complexes with FK506 and rapamycin. J. Mol. Biol. 229:105-124.
36. Marks, A.R. 1996. Cellular functions of immunophillins. Physiol. Rev. 76:631-649.
37. Brillantes, A.-M.B., K. Ondrias, A. Scott, E. Kobrinsky, E. Ondriasova, M.C. Moschella, T. Jayaraman, M. Landers, B.E. Ehrlich, and A.R. Marks. 1994. Stabilization of calcium release channel (ryanodine receptor) function by FK-506 binding protein. Cell. 77:513-523.
38. Timerman, A.P., T. Jayaraman, G. Wiederrecht, H. Onoue, A. Marks, and S. Fleischer. 1994. The ryanodine receptor from canine heart sarcoplasmic reticulum is associated with a novel FK-506 binding protein. BBRC. 198:701-706.
39. Cameron, A.M., J.P. Steiner, D.M. Sabatini, A.I. Kaplin, L.D. Walensky, and S.H. Snyder. 1995. Immunophilin FK506 binding protein associated with inositol 1,4,5-trisphosphate receptor modulates calcium influx. Proc. Natl. Acad. Sci. USA. 92:1784-1788.
40. Cardenas, M.E., C. Hemenway, R.S. Muir, R. Ye, D. Fiorentino, and J. Heitman. 1995. Immunophilins interact with calcineurin in the absence of exogenous immunosuppressive ligands. EMBO (Eur. Mol. Biol. Organ.) J. 13:5944-5957.